Abstract:BackgroundBoth ketamine and methamphetamine have been used for studying the positive, negative, and cognitive symptoms, and dopaminergic and GABAergic dysfunction observed in acute schizophrenia. We aimed to explore and compare the prevalence and factor structure of psychotic symptoms in chronic ketamine and methamphetamine users.MethodsWe recruited chronic ketamine and methamphetamine users from the Guangzhou Baiyun and Kangda voluntary drug rehabilitation centres in the Hunan Province, China. All these participants met the Diagnostic and Statistical Manual of Mental Disorders, fourth edition criteria for lifetime ketamine or methamphetamine dependence determined from the Structured Clinical Interview. Participants were excluded if they met criteria for other substance dependence (excluding nicotine) at any time. All participants gave a full history of psychiatric symptoms. We used The Positive and Negative Syndrome Scale (PANSS) to assess the psychotic symptoms in these two groups. Independent sample t-tests or χ2-square test were done to determine group differences. The protocol was approved by the university ethics committee (S163, 2011).FindingsWe recruited 344 chronic ketamine users (34 were female; mean age 26·8 years, SD 5·43; mean years of education 11·6 years, SD 2·45) and 456 chronic methamphetamine users (28 were female; mean age 29·3 years SD 6·33, mean years of education 11·1 years, SD 2·78) between Jan 1, 2012, to Dec 31, 2015. 183 (53%) of 344 ketamine users and 375 (82%) of 456 methamphetamine users (χ2 t=78·37, p<0·0001) had psychiatric symptoms, with a mean duration of 23·5 months (SD 24·58) for ketamine users and 15·0 months (SD 19·42) for methamphetamine users (t=4·05, p<0·0001). The mean age when first having psychotic symptoms was 25·4 years (SD 5·55) in ketamine users and 28·5 years (6·33) in methamphetamine users (t=–5·84, p<0·0001). Mean scores on PANSS TOTAL were 52·6 (SD 23·34) in ketamine users and 61·7 (29·61) in methamphetamine users (t=–4·84, p<0·0001). Mean scores for ketamine and methamphetamine use groups on positive, negative, and general subscales were 10·8 (SD 5·45) versus 15·0 (8·26; t=–8·80, p<0·0001), 12·2 (6·91) versus 14·5 (8·68; t=–4·07, p<0·0001), and 29·7 (12·98) versus 32·2 (15·22; t=–2·55, p=0·011), respectively.InterpretationThis study provides first evidence for comparing psychotic symptoms in chronic ketamine and chronic methamphetamine users. The findings suggest that chronic methamphetamine users have higher risk of suffering from psychiatric symptoms and more severity of chronic drug-induced schizophrenia-like symptoms than do chronic ketamine users. These findings might provide some implications for pharmacological (glutamatergic and dopaminergic) models of schizophrenia.FundingNatural Science Foundation of China (81100996 to YL, and 81371480 to JT). The funder of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report. The corresponding authors had full access to all the data in the study and had final responsibility for the decision to submit for publication.

A Preliminary Study of Methamphetamine Use in Yunnan, China.

Prevalence and Correlates of Hiv and Hcv Infection among Amphetamine-Type Stimulant Users in 6 Provinces in China

Risk sexual behaviors and prevention of aids among synthetic drug users

HIV, Syphilis, and Condom Use among Female Drug Users in Maanshan, China

Analysis of Risk Behaviors of HIV Infection among Male Population Aged 18～49 in Yunnan Province

Psychiatric Symptoms in Individuals Who Use Ketamine Versus Methamphetamine—implications for Glutamatergic and Dopaminergic Model for Schizophrenia: a Cohort Study

Gender Differences in Socio-Demographic and Clinical Characteristics of Methamphetamine Inpatients in a Chinese Population

THE SITUATION OF AMPHETAMINE-TYPE STIMULANTS ABUSEAND THE RELATED FACTORS ON HIV/STD IN YUNNAN PROVINCE

Illicit Heroin And Methamphetamine Use Among Methadone Maintenance Treatment Patients In Dehong Prefecture Of Yunnan Province, China

Epidemiological Characteristics and Risk Factors of Methamphetamine-Associated Psychotic Symptoms

New Types of Drug Use and Risks of Drug Use among Men Who Have Sex with Men: a Cross-Sectional Study in Hangzhou, China

High Prevalence of Hiv, Syphilis and Hcv, and Low Methadone Maintenance Treatment in A Migrant Population in Beijing

INVESTIGATION ON METHAMPHETAMINE USE AMONG PATIENTS ON METHADONE MAINTENANCE TREATMENT IN RUILI

Impact of methamphetamine use on HIV and other health outcomes at an urban HIV medicine clinic

Tobacco and Alcohol Use among Drug Users Receiving Methadone Maintenance Treatment: A Cross-Sectional Study in A Rural Prefecture of Yunnan Province, Southwest China

Prevalence, demographics, and clinical correlates of antisocial personality disorder in Chinese methamphetamine patients

Differences in sexual risk behaviors among male and female HIV-seronegative heterosexual methamphetamine users

[Prevalence and Network-Characteristics of Risky Sexual Behaviors among Clients Receiving Methadone Maintenance Treatment at Clinics in Taizhou Prefecture of Zhejiang Province].

Exploring stakeholder perceptions of facilitators and barriers to using needle exchange programs in Yunnan Province, China

High Prevalence Of Hiv, Hcv And Tuberculosis And Associated Risk Behaviours Among New Entrants Of Methadone Maintenance Treatment Clinics In Guangdong Province, China

Exploratory analysis of the association between new-type drug use and sexual transmission of HIV in China.